Biomarker testing is quite literally saving my life.
I am one of the lucky ones. I live in a state that, in theory, prioritizes this cutting-edge care. Thanks to a 2023 law, biomarker testing coverage is now required for both state-regulated private insurance and Medicaid in Maryland. But as I have learned through a grueling journey of biopsies and bills, a law on the books is only as good as its enforcement.
It is time for Maryland to move beyond the “signing ceremony” phase and redouble its efforts to ensure that insurance companies comply with the law. Every resident deserves the full benefits of precision medicine, free from insurance companies’ administrative interference…